GlassScriptPhysician profile
Brian H Moss
NPI 1013134394
$5,253.62
in general payments reported to CMS, 2019-2025
27 companies · $1,022 in 2025
The $1,022 reported for 2025 was more than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $704 · 2020: $1,277 · 2021: $266 · 2022: $874 · 2023: $498 · 2024: $614 · 2025: $1,022.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,089 · Travel and Lodging: $567 · Consulting Fee: $478.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,089.05 |
| Travel and Lodging | $566.67 |
| Consulting Fee | $478.48 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medwest Associates | $1,063.00 | 2020-2022 | |
| Linvatec Corporation | $649.52 | 2025 | Biobrace 23mm, Livatec Knee Preservation System |
| Stryker Corporation | $627.72 | 2019-2025 | Mako, Hoffmann |
| Carbofix Orthopedics INC | $478.48 | 2023-2025 | |
| Electronic Waveform Lab, INC. | $301.20 | 2019 | |
| Oak Med, INC. | $296.06 | 2024-2025 | |
| Pacira Therapeutics, INC. | $258.92 | 2019-2021 | |
| Ferring Pharmaceuticals INC. | $204.85 | 2019-2024 | Euflexxa |
| Catalyst Orthoscience | $185.33 | 2022 | |
| Wright Medical Technology, INC. | $161.52 | 2019-2020 | |
| Think Surgical, INC. | $150.00 | 2024 | |
| Depuy Synthes Sales INC. | $139.55 | 2022-2025 | Monovisc, Orthovisc |
| Fidia Pharma USA INC. | $128.20 | 2023-2025 | Hymovis, Triluron, Hyalgan |
| Bioventus LLC | $116.55 | 2020-2024 | L300 Go System |
| Zimmer Biomet Holdings, INC. | $115.83 | 2021 |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Orthofix Medical, INC. | $100.19 | 2023-2025 | Physio-Stim |
| Smith+Nephew, INC. | $63.64 | 2020 | |
| Abbott Laboratories | $38.49 | 2020-2022 | |
| Horizon Therapeutics Plc | $31.42 | 2021-2022 | |
| Boston Scientific Corporation | $26.25 | 2025 | General - Pain Management |
| E.R. Squibb & Sons, L.L.C. | $23.98 | 2020-2021 | |
| Vericel Corporation | $23.62 | 2022 | |
| Pfizer INC. | $15.87 | 2021 | |
| Kci USA, INC. | $14.89 | 2019 | |
| Sanofi-Aventis U.S. LLC | $13.13 | 2020 | |
| Medtronic USA, INC. | $12.96 | 2019 | |
| Ethicon US, LLC | $12.45 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brian Moss listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.